Multifocality and multicentricity in breast cancer and survival outcomes

Annals of Oncology

Volumn 23, Issue 12, 2012, Pages 3063-3069

  Lynch, S P ^a   Lei, X ^a   Chavez Macgregor, M ^a   Hsu, L ^a   Meric Bernstam, F ^a   Buchholz, T A ^a   Zhang, A ^a   Hortobagyi, G N ^a   Valero, V ^a   Gonzalez Angulo, A M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Multicentric; Multifocal; Outcomes

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

AFRICAN AMERICAN; ARTICLE; BREAST CANCER; BREAST CANCER SPECIFIC SURVIVAL; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; HORMONAL THERAPY; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SURVIVAL TIME;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84869855171     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds136     Document Type: Article

References (23)

1. Yerushalmi R, Kennecke H, Woods R et al. Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res Treat 2009; 117: 365-370.
2. Egan RL. Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer 1982; 49: 1123-1130.
3. Wilkinson LS, Given-Wilson R, Hall T et al. Increasing the diagnosis of multifocal primary breast cancer by the use of bilateral whole-breast ultrasound. Clin Radiol 2005; 60: 573-578.
4. Sardanelli F, Giuseppetti GM, Panizza P et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol 2004; 183: 1149-1157.
5. Houssami N, Ciatto S, Macaskill P et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008; 26: 3248-3258.
6. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181-187.
7. Andea AA, Wallis T, Newman LA et al. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer 2002; 94: 1383-1390.
8. Andea AA, Bouwman D, Wallis T et al. Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer 2004; 100: 20-27.
9. Coombs NJ, Boyages J. Multifocal and multicentric breast cancer: does each focus matter? J Clin Oncol 2005; 23: 7497-7502.
10. Pedersen L, Gunnarsdottir KA, Rasmussen BB et al. The prognostic influence of multifocality in breast cancer patients. Breast 2004; 13: 188-193.
11. Weissenbacher TM, Zschage M, Janni W et al. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? Breast Cancer Res Treat 2010; 122: 27-34.
12. Cabioglu N, Ozmen V, Kaya H et al. Increased lymph node positivity in multifocal and multicentric breast cancer. J Am Coll Surg 2009; 208: 67-74.
13. Rezo A, Dahlstrom J, Shadbolt B et al. Tumor size and survival in multicentric and multifocal breast cancer. Breast 2011; 20: 259-263.
14. Tot T, Gere M, Pekar G et al. Breast cancer multifocality, disease extent, and survival. Hum Pathol 2011; 42: 1761-1769.
15. Edge SB, Compton CC, Fritz AG et al. AJCC Cancer Staging Manual; New York: Springer, 2009.
16. Fisher ER, Gregorio R, Redmond C et al. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol no. 4). I. Observations concerning the multicentricity of mammary cancer. Cancer 1975; 35: 247-254.
17. Rakovitch E, Pignol JP, Hanna W et al. Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy. J Clin Oncol 2007; 25: 5591-5596.
18. Katz A, Strom EA, Buchholz TA et al. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 2001; 50: 735-742.
19. Gupta D, Nath M, Layfield LJ. Utility of four-quadrant random sections in mastectomy specimens. Breast J 2003; 9: 307-311.
20. Vlastos G, Rubio IT, Mirza NQ et al. Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer. Ann Surg Oncol 2000; 7: 581-587.
21. Joergensen LE, Gunnarsdottir KA, Lanng C et al. Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996-2001. Breast 2008; 17: 587-591.
22. Litton JK, Eralp Y, Gonzalez-Angulo AM et al. Multifocal breast cancer in women ≤35 years old. Cancer 2007; 110: 1445-1450.
23. Boyages J, Jayasinghe UW, Coombs N. Multifocal breast cancer and survival: each focus does matter particularly for larger tumours. Eur J Cancer 2010; 46: 1990-1996.